Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China
OBJECTIVE: To examine the clinical outcomes and associated prognostic factors among patients with multidrug-resistant tuberculosis (MDR-TB) in China.METHODS: This retrospective study involved 243 patients with MDR-TB. All patients received standard regimens containing para-amino salicylic acid (PAS)...
Saved in:
Published in | The international journal of tuberculosis and lung disease Vol. 22; no. 3; pp. 300 - 305 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
France
International Union Against Tuberculosis and Lung Disease
01.03.2018
International Union against Tuberculosis and Lung Disease (IUATLD) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | OBJECTIVE: To examine the clinical outcomes and associated prognostic factors among patients with multidrug-resistant tuberculosis (MDR-TB) in China.METHODS: This retrospective study involved 243 patients with MDR-TB. All patients received standard regimens containing para-amino
salicylic acid (PAS) and/or cycloserine (CS). The demographic, social and clinical characteristics of patients were recorded and the patients were followed up for 24 months.RESULTS: Treatment success was closely associated with young age, non-farming occupations, shorter history or smoking,
normal urine results, initial MDR-TB treatment regimen, increased haemoglobin, direct bilirubin, uric acid and thyroid stimulating hormone (TSH) levels, and lower white blood cell, neutrophil and blood platelet counts (all P < 0.05). On multivariable analysis, increased haemoglobin
(hazard ratio [HR] 1.019, 95%CI 1.007-1.032, P = 0.002) and TSH levels (HR 1.002, 95%CI 1.006-1.039, P = 0.008), normal urine results (HR 1.541, 95%CI 1.008-2.358, P = 0.046) and initial MDR-TB treatment regimen (HR 2.238, 95%CI 1.090-4.597, P
= 0.028) were prognostic factors for treatment success in MDR-TB.CONCLUSIONS: Higher haemoglobin and TSH levels, normal urine results and initial MDR-TB treatment regimen might predict successful treatment of MDR-TB. |
---|---|
Bibliography: | (R) Medicine - General 1027-3719(20180301)22:3L.300;1- ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1027-3719 1815-7920 |
DOI: | 10.5588/ijtld.17.0183 |